Main Title |
Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies |
CORP Author |
European Commission. Scientific Committee on Emerging and Newly Identified Health Risks. |
Publisher |
Scientific Committee on Emerging and Newly Identified Health Risks, |
Year Published |
2005 |
OCLC Number |
62147467 |
Subjects |
Nanotechnology ;
Risk assessment
|
Internet Access |
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
EJBM |
T174.7.E976 2005 |
|
Headquarters Library/Washington,DC |
10/28/2005 |
|
Collation |
78 p. ; 28 cm. |
Notes |
Adopted by the SCENIHR during the 7th plenary meeting of 28-29 September 2005. Includes bibliographical references (p. 62-77) |
Contents Notes |
Background -- Terms of Reference -- Scientific rational -- Introduction -- Definitions and scope -- Nanoscience and nanotechnology -- Examples of engineered nanostructures and materials and their applications -- Essentials of nanostructure generation: top-down vs. bottom-up chemical and physical self assembly -- Nanoscale materials properties -- Conclusions -- Nanoparticles: Physical and chemical particles -- Nanoparticle - nanoparticle interaction -- Sources of free nanoparticles -- Formation of nanoparticles in the liquid phase -- Formation of nanoparticles suspended in the gas phase -- Environmental sources of airborne nanoparticles -- Occupational sources of airborne nanoparticles -- Nanoparticles in and from consumer products -- Detection and measurement on nanoparticles -- In situ and on-line detection principles for nanoparticles in gas suspension -- In situ and on-line detection of particles in a liquid medium -- Potential for interactions between nanoparticles and living systems -- Nanoparticles in living systems - the surface effects -- Effects of size, shape, surface and bulk composition -- Solubility and persistence -- Toxicology of nanoparticles -- Mediators of the toxicity of particles -- Inhaled particles -- Particles for drug delivery -- Toxicological testing -- Exposure scenarios -- Sampling -- Exposure assessment methodologies -- General exposure considerations -- Hazard considerations -- Scope of nanoparticle risk assessment -- Exposure assessment methodology -- Hazard identification and hazard characterization methodology -- Risk characterization and integrated risk assessment -- Critical gaps in knowledge required for risk assessment purposes -- Regulatory and other aspects related to risk assessment -- Other needed developments -- Prioritisation of needs in knowledge -- Committee opinion -- Minority opinion. |